Physician profile
David J Edelstein
NPI 1023075066
$918.47
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $276 · 2021: $121 · 2022: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $291.37 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $230.69 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $95.23 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $87.05 | 2019-2021 | |
| Alcon Vision LLC | $84.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $57.84 | 2019 | |
| Bausch & Lomb Americas INC. | $38.46 | 2022 | |
| Boston Scientific Corporation | $33.56 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Edelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.